Items where authors include "Chan, S."

Article

Fish, R. orcid.org/0000-0002-4239-6993, Blackwell, S. orcid.org/0000-0002-2819-3727, Knight, S.R. orcid.org/0000-0003-0448-3719 et al. (308 more authors) (2024) Defining standards and core outcomes for clinical trials in prehabilitation for colorectal surgery (DiSCO): modified Delphi methodology to achieve patient and healthcare professional consensus. British Journal of Surgery, 111 (6). znae056. ISSN 0007-1323

Chan, S. orcid.org/0000-0002-4021-0032 (2023) Constructions of race in advertising archives: The “silent” Chinese minority. Alphaville: journal of film and screen media (25). pp. 104-114. ISSN 2009-4078

Fennell, D.A., Ewings, S., Ottensmeier, C. et al. (36 more authors) (2021) Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial. The Lancet Oncology, 22 (11). pp. 1530-1540. ISSN 1470-2045

Erikainen, S., Friesen, P., Rand, L. et al. (33 more authors) (2021) Public involvement in the governance of population-level biomedical research: unresolved questions and future directions. Journal of Medical Ethics, 47 (7). pp. 522-525. ISSN 0306-6800

Chan, S. and Weich, S. orcid.org/0000-0002-7552-7697 (2020) Mental well-being and recovery in serious mental illness : associations between mental well-being and functional status in the health survey for England 2014. BJPsych Open, 6 (4). e66. ISSN 2056-4724

Schmid, P., Zaiss, M., Harper-Wynne, C. et al. (29 more authors) (2019) Fulvestrant plus vistusertib vs fulvestrant plus everolimus vs fulvestrant alone for women with hormone receptor–positive metastatic breast cancer: the MANTA phase 2 randomized clinical trial. JAMA Oncology, 5 (11). pp. 1556-1564. ISSN 2374-2445

Cornes, P., Gascon, P., Chan, S. et al. (5 more authors) (2018) Systematic review and meta-analysis of short- versus long-acting granulocyte colony-stimulating factors for reduction of chemotherapy-induced febrile neutropenia. Advances in Therapy, 35 (11). pp. 1816-1829. ISSN 0741-238X

Tutt, A., Tovey, H., Cheang, M.C.U. et al. (35 more authors) (2018) Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. Nature Medicine, 24 (5). pp. 628-637. ISSN 1078-8956

Albarakati, N., Abdel-Fatah, T.M.A., Doherty, R. orcid.org/0000-0002-3979-961X et al. (14 more authors) (2014) Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy. Molecular Oncology , 9 (1). pp. 204-217. ISSN 1574-7891